Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Long-term use of recombinant IFN-gamma evaluated

Feb. 24, 1997

Antiadhesion product enters clinical trials

Feb. 21, 1997

Schering-Plough seeks FDA approval for psoriasis treatment

Feb. 20, 1997

Schering AG investigates vitamin D derivatives

Feb. 20, 1997

Novel LTB4 receptor antagonist described

Feb. 20, 1997

Antiacne treatment available in the U.K.

Feb. 19, 1997

Dermik launches new acne medication

Feb. 14, 1997

Gliatech's ADCON-L nears FDA approval

Feb. 14, 1997

Penederm receives U.K. marketing approval for topical acne treatment

Feb. 13, 1997

Development partner sought for new wound dressing

Feb. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...